Related Experiment Video
Updated: Jul 23, 2026

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
Published on: October 25, 2013
Occurrence and mechanisms of glycopeptide resistance in gram-positive cocci
1Section of Pediatric Infectious Diseases, Wyler Children's Hospital, University of Chicago, Illinois 60637.
Abstract:
Despite belief that the unique mechanism of glycopeptide action would preclude the development of resistance in susceptible organisms, clinical isolates of enterococci and staphylococci resistant to these compounds have been described. Among the enterococci, there are at least three types of resistance. Type A (high-level) resistance was described in Enterococcus faecium and E. faecalis. It is inducible and mediated by elaboration and/or increased activity of at least three enzymes: a ligase, a dehydrogenase, and a carboxypeptidase, which orchestrate the production of peptidoglycan precursors that do not bind vancomycin. Type B (low-level) resistance described in E. faecium is also mediated by increased carboxypeptidase activity and, possibly, by elaboration of a protein detectable after incubation in vancomycin whose function is unknown. Type C resistance is associated with production of a ligase constitutively produced, chromosomally encoded, and unique to E. gallinarum. Among the staphylococci, coagulase-negative clinical isolates were obtained that were resistant to glycopeptides and one coagulase-positive isolate was resistant to teicoplanin but the mechanism of resistance is unknown. Additionally, coagulase-positive staphylococci resistant to glycopeptides have been prepared in the laboratory. They produce an approximately 39-kDa cytoplasmic protein, whose function is unknown, and have undergone extensive reorganization of their cell surface. The era in which universal gram-positive susceptibility to glycopeptides can be presumed is over; susceptibility testing must now accompany isolation of an enterococcus or staphylococcus of clinical importance.
Insights
Glycopeptide resistance in enterococci and staphylococci is a growing concern. Understanding the mechanisms of resistance is crucial for effective treatment strategies against these Gram-positive bacteria.
Area of Science:
- Microbiology
- Molecular Biology
- Infectious Diseases
Background:
- Glycopeptides were once thought to be immune to resistance development due to their unique mechanism of action.
- However, clinical isolates of enterococci and staphylococci exhibiting resistance to glycopeptides have emerged.
- This necessitates a re-evaluation of susceptibility assumptions for these critical pathogens.
Purpose of the Study:
- To investigate and describe the mechanisms of glycopeptide resistance in clinically significant enterococci and staphylococci.
- To highlight the diversity of resistance types within enterococcal species.
- To characterize novel resistance mechanisms observed in staphylococci.
Main Methods:
- Characterization of enzymatic activities (ligase, dehydrogenase, carboxypeptidase) involved in peptidoglycan precursor synthesis.
- Induction studies to assess the role of enzymes in resistance.
- Genetic analysis to identify chromosomal or inducible resistance determinants.
- Proteomic analysis to identify novel proteins associated with resistance.
- Laboratory-induced resistance studies in staphylococci.
Main Results:
- Enterococci exhibit at least three distinct resistance types (A, B, and C) mediated by altered enzyme activity or novel protein production.
- Type A resistance involves inducible enzymes affecting peptidoglycan precursors.
- Type C resistance in E. gallinarum is linked to a constitutively produced, chromosomally encoded ligase.
- Staphylococcal resistance mechanisms, including a 39-kDa protein and cell surface reorganization, are still under investigation.
Conclusions:
- The era of presumed universal Gram-positive susceptibility to glycopeptides is over.
- Distinct molecular mechanisms underlie glycopeptide resistance in enterococci and staphylococci.
- Routine susceptibility testing is now essential for clinical isolates of enterococci and staphylococci.
More Related Videos
08:19Generating Transposon Insertion Libraries in Gram-Negative Bacteria for High-Throughput Sequencing
Published on: July 7, 2020
08:58Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes
Published on: March 3, 2023
Related Concept Videos
Bacterial Cell Wall
Development of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Inhibitors of Gram-positive Cell Wall Synthesis
Inhibitors of Bacterial Protein Synthesis
Clinical Significance of Antibiotic Resistance